Interleukin-2 (IL-2) is involved in the activation and differentiation of T-helper cells. Uncontrolled activated T cells play a key role in the pathophysiology by stimulating inflammation and autoimmune diseases like arthritis, psoriasis and Crohn’s disease. T cells activation can be suppressed either by preventing IL-2 production or blocking the IL-2 interaction with its receptor. Hence, IL-2 is now emerging as a target for novel therapeutic approaches in several autoimmune disorders. This study was carried out to set up an effective virtual screening (VS) pipeline for IL-2. Four docking/scoring approaches (FRED, MOE, GOLD and Surflex-Dock) were compared in the re-docking process to test their performance in producing correct binding modes...
Cyclooxygenase-2 (COX-2) produces prostaglandins in inflamed tissues and hence has been considered a...
Phospholipase A2 (PLA2) is an enzyme that induces inflammation, making PLA2 activity an effective ap...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
A wealth of literature has highlighted the discovery of various immune modulators, frequently used i...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
An in silico Molecular Dynamics (MD) docking investigation with 4,634 drugs was conducted to identif...
International audienceInterleukin (IL)-15 is a pleiotropic cytokine, which is structurally close to ...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
Recovery of the P53 tumour suppressor pathway via small molecule inhibitors of onco-protein MDM2 hig...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
Virtual screenings based on molecular docking play a major role in medicinal chemistry for the ident...
Target structure-based virtual screening, which employs protein-small molecule docking to identify p...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
A gain-of-function mutant of the lymphoid phosphatase Lyp (PTPN22) has recently been implicated in t...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
Cyclooxygenase-2 (COX-2) produces prostaglandins in inflamed tissues and hence has been considered a...
Phospholipase A2 (PLA2) is an enzyme that induces inflammation, making PLA2 activity an effective ap...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
A wealth of literature has highlighted the discovery of various immune modulators, frequently used i...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
An in silico Molecular Dynamics (MD) docking investigation with 4,634 drugs was conducted to identif...
International audienceInterleukin (IL)-15 is a pleiotropic cytokine, which is structurally close to ...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
Recovery of the P53 tumour suppressor pathway via small molecule inhibitors of onco-protein MDM2 hig...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
Virtual screenings based on molecular docking play a major role in medicinal chemistry for the ident...
Target structure-based virtual screening, which employs protein-small molecule docking to identify p...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
A gain-of-function mutant of the lymphoid phosphatase Lyp (PTPN22) has recently been implicated in t...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...
Cyclooxygenase-2 (COX-2) produces prostaglandins in inflamed tissues and hence has been considered a...
Phospholipase A2 (PLA2) is an enzyme that induces inflammation, making PLA2 activity an effective ap...
The development of novel medicines to treat autoimmune diseases and SARS-CoV-2 main protease (Mpro),...